The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3,5-dimethylphenyl)-4-(4-(4-fluorophenyl)-1-(piperidin-4-yl)-1H-imidazol-5-yl)pyrimidin-2-amine ID: ALA4521096
PubChem CID: 137701509
Max Phase: Preclinical
Molecular Formula: C26H27FN6
Molecular Weight: 442.54
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C)cc(Nc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1
Standard InChI: InChI=1S/C26H27FN6/c1-17-13-18(2)15-21(14-17)31-26-29-12-9-23(32-26)25-24(19-3-5-20(27)6-4-19)30-16-33(25)22-7-10-28-11-8-22/h3-6,9,12-16,22,28H,7-8,10-11H2,1-2H3,(H,29,31,32)
Standard InChI Key: DGOVBHLIYNOJOQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
4.6954 -21.5482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6942 -22.3678 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4023 -22.7767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1119 -22.3673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1091 -21.5446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4005 -21.1394 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9876 -21.1398 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9874 -20.3226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6974 -19.9162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6975 -19.0997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9892 -18.6905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2792 -19.1036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2826 -19.9187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4071 -23.5939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7458 -24.0741 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9982 -24.8513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8154 -24.8515 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0680 -24.0744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8399 -23.8222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4471 -24.3709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2237 -24.1191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3943 -23.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7823 -22.7712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0080 -23.0259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1713 -23.0656 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.9720 -23.8242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8040 -23.0235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0309 -22.7700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4204 -23.3138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5884 -24.1145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3669 -24.3714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5700 -18.6977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4054 -18.6913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 2 0
3 14 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
18 19 1 0
22 25 1 0
26 27 1 0
26 31 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
15 26 1 0
12 32 1 0
10 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 442.54Molecular Weight (Monoisotopic): 442.2281AlogP: 5.43#Rotatable Bonds: 5Polar Surface Area: 67.66Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.37CX Basic pKa: 10.13CX LogP: 5.07CX LogD: 2.46Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.43Np Likeness Score: -1.19
References 1. Divakaran A, Talluri SK, Ayoub AM, Mishra NK, Cui H, Widen JC, Berndt N, Zhu JY, Carlson AS, Topczewski JJ, Schonbrunn EK, Harki DA, Pomerantz WCK.. (2018) Molecular Basis for the N-Terminal Bromodomain-and-Extra-Terminal-Family Selectivity of a Dual Kinase-Bromodomain Inhibitor., 61 (20): [PMID:30253095 ] [10.1021/acs.jmedchem.8b01248 ] 2. Cui H, Divakaran A, Hoell ZJ, Ellingson MO, Scholtz CR, Zahid H, Johnson JA, Griffith EC, Gee CT, Lee AL, Khanal S, Shi K, Aihara H, Shah VH, Lee RE, Harki DA, Pomerantz WCK.. (2022) A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes., 65 (3.0): [PMID:35007061 ] [10.1021/acs.jmedchem.1c01779 ] 3. Divakaran A, Scholtz CR, Zahid H, Lin W, Griffith EC, Lee RE, Chen T, Harki DA, Pomerantz WCK.. (2022) Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader., 13 (10.0): [PMID:36262390 ] [10.1021/acsmedchemlett.2c00300 ]